retatrutide what is it Retatrutide: 24% Weight Loss Without Dieting? Retatrutide Promises Big Weight Loss,

Survodutide: Dual Receptor Strategy Survodutide activates GLP-1 and glucagon receptors without GIP receptor involvement

You get it through a weekly injection

Clinical studies show no evidence of metabolic acceleration that would offset the natural decline in energy requirements accompanying weight reduction

Conflicts of Interest: From the study, several coauthors were Eli Lilly employees, and the sponsor designed and oversaw the trial, conducted site monitoring, data collation, and data analysis, with the last author also an employee of the sponsor

The effect of ursodeoxycholic acid in dissolving gallstones formed after laparoscopic sleeve gastrectomy: retrospective cohort study